67 related articles for article (PubMed ID: 18039688)
21. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
[TBL] [Abstract][Full Text] [Related]
22. Pilot study to determine the feasibility of producing protease-resistant prion protein fragments by random PCR mutagenesis.
Dear DV; Fitzmaurice TJ; Garton S; Richards SJ
Biochem Biophys Res Commun; 2001 Mar; 281(4):929-35. PubMed ID: 11237750
[TBL] [Abstract][Full Text] [Related]
23. Deciphering Copper Coordination in the Mammalian Prion Protein Amyloidogenic Domain.
Salzano G; Brennich M; Mancini G; Tran TH; Legname G; D'Angelo P; Giachin G
Biophys J; 2020 Feb; 118(3):676-687. PubMed ID: 31952810
[TBL] [Abstract][Full Text] [Related]
24. Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formation.
Cappai R; Stewart L; Jobling MF; Thyer JM; White AR; Beyreuther K; Collins SJ; Masters CL; Barrow CJ
Biochemistry; 1999 Mar; 38(11):3280-4. PubMed ID: 10079070
[TBL] [Abstract][Full Text] [Related]
25. Prion protein interaction with glycosaminoglycan occurs with the formation of oligomeric complexes stabilized by Cu(II) bridges.
González-Iglesias R; Pajares MA; Ocal C; Espinosa JC; Oesch B; Gasset M
J Mol Biol; 2002 May; 319(2):527-40. PubMed ID: 12051926
[TBL] [Abstract][Full Text] [Related]
26. Biosensing of lipid-prion interactions: insights on charge effect, Cu(II)-ions binding and prion oligomerization.
Steunou S; Chich JF; Rezaei H; Vidic J
Biosens Bioelectron; 2010 Dec; 26(4):1399-406. PubMed ID: 20692152
[TBL] [Abstract][Full Text] [Related]
27. Zinc, copper, and carnosine attenuate neurotoxicity of prion fragment PrP106-126.
Kawahara M; Koyama H; Nagata T; Sadakane Y
Metallomics; 2011 Jul; 3(7):726-34. PubMed ID: 21442127
[TBL] [Abstract][Full Text] [Related]
28. A role for His155 in binding of human prion peptide144-167 to immobilised prion protein.
Hesp JR; Raven ND; Sutton JM
Biochem Biophys Res Commun; 2007 Oct; 362(3):695-9. PubMed ID: 17761148
[TBL] [Abstract][Full Text] [Related]
29. Sheep prion protein synthetic peptide spanning helix 1 and beta-strand 2 (residues 142-166) shows beta-hairpin structure in solution.
Kozin SA; Bertho G; Mazur AK; Rabesona H; Girault JP; Haertlé T; Takahashi M; Debey P; Hoa GH
J Biol Chem; 2001 Dec; 276(49):46364-70. PubMed ID: 11577109
[TBL] [Abstract][Full Text] [Related]
30. Effect of enzymatic deimination on the conformation of recombinant prion protein.
Young DS; Meersman F; Oxley D; Webster J; Gill AC; Bronstein I; Lowe CR; Dear DV
Biochim Biophys Acta; 2009 Aug; 1794(8):1123-33. PubMed ID: 19341825
[TBL] [Abstract][Full Text] [Related]
31. Stability and Cu(II) binding of prion protein variants related to inherited human prion diseases.
Cereghetti GM; Schweiger A; Glockshuber R; Van Doorslaer S
Biophys J; 2003 Mar; 84(3):1985-97. PubMed ID: 12609901
[TBL] [Abstract][Full Text] [Related]
32. Scrapie-infected cells, isolated prions, and recombinant prion protein: a comparative study.
Kneipp J; Miller LM; Spassov S; Sokolowski F; Lasch P; Beekes M; Naumann D
Biopolymers; 2004 May-Jun 5; 74(1-2):163-7. PubMed ID: 15137116
[TBL] [Abstract][Full Text] [Related]
33. pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231).
Swietnicki W; Petersen R; Gambetti P; Surewicz WK
J Biol Chem; 1997 Oct; 272(44):27517-20. PubMed ID: 9346881
[TBL] [Abstract][Full Text] [Related]
34. Constant-pH molecular dynamics simulations reveal a β-rich form of the human prion protein.
Campos SR; Machuqueiro M; Baptista AM
J Phys Chem B; 2010 Oct; 114(39):12692-700. PubMed ID: 20843095
[TBL] [Abstract][Full Text] [Related]
35. The key-role of tyrosine 155 in the mechanism of prion transconformation as highlighted by a study of sheep mutant peptides.
Bertho G; Bouvier G; Hoa GH; Girault JP
Peptides; 2008 Jul; 29(7):1073-84. PubMed ID: 18455265
[TBL] [Abstract][Full Text] [Related]
36. Rapid acquisition of beta-sheet structure in the prion protein prior to multimer formation.
Post K; Pitschke M; Schäfer O; Wille H; Appel TR; Kirsch D; Mehlhorn I; Serban H; Prusiner SB; Riesner D
Biol Chem; 1998 Nov; 379(11):1307-17. PubMed ID: 9865603
[TBL] [Abstract][Full Text] [Related]
37. Simulations of biomolecules: Characterization of the early steps in the pH-induced conformational conversion of the hamster, bovine and human forms of the prion protein.
Alonso DO; An C; Daggett V
Philos Trans A Math Phys Eng Sci; 2002 Jun; 360(1795):1165-78. PubMed ID: 12804272
[TBL] [Abstract][Full Text] [Related]
38. Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry.
Whittal RM; Ball HL; Cohen FE; Burlingame AL; Prusiner SB; Baldwin MA
Protein Sci; 2000 Feb; 9(2):332-43. PubMed ID: 10716185
[TBL] [Abstract][Full Text] [Related]
39. Checking the pH-induced conformational transition of prion protein by molecular dynamics simulations: effect of protonation of histidine residues.
Langella E; Improta R; Barone V
Biophys J; 2004 Dec; 87(6):3623-32. PubMed ID: 15377536
[TBL] [Abstract][Full Text] [Related]
40. Raman spectroscopic study on the copper(II) binding mode of prion octapeptide and its pH dependence.
Miura T; Hori-i A; Mototani H; Takeuchi H
Biochemistry; 1999 Aug; 38(35):11560-9. PubMed ID: 10471308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
